These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 25604253)

  • 21. Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing.
    Hanson B; Wood MJA; Roberts TC
    RNA Biol; 2021 Jul; 18(7):1048-1062. PubMed ID: 33472516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy.
    Aartsma-Rus A; Bremmer-Bout M; Janson AA; den Dunnen JT; van Ommen GJ; van Deutekom JC
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S71-7. PubMed ID: 12206800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in carrier frequency between mothers of Duchenne and Becker muscular dystrophy patients.
    Lee T; Takeshima Y; Kusunoki N; Awano H; Yagi M; Matsuo M; Iijima K
    J Hum Genet; 2014 Jan; 59(1):46-50. PubMed ID: 24225992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations.
    Juan-Mateu J; Gonzalez-Quereda L; Rodriguez MJ; Baena M; Verdura E; Nascimento A; Ortez C; Baiget M; Gallano P
    PLoS One; 2015; 10(8):e0135189. PubMed ID: 26284620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of exonic rearrangements and frame shifts in the dystrophin gene in Duchenne muscular dystrophy patients in a Saudi community.
    Elhawary NA; Jiffri EH; Jambi S; Mufti AH; Dannoun A; Kordi H; Khogeer A; Jiffri OH; Elhawary AN; Tayeb MT
    Hum Genomics; 2018 Apr; 12(1):18. PubMed ID: 29631625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exons 45-55 Skipping Using Mutation-Tailored Cocktails of Antisense Morpholinos in the DMD Gene.
    Echigoya Y; Lim KRQ; Melo D; Bao B; Trieu N; Mizobe Y; Maruyama R; Mamchaoui K; Tanihata J; Aoki Y; Takeda S; Mouly V; Duddy W; Yokota T
    Mol Ther; 2019 Nov; 27(11):2005-2017. PubMed ID: 31416775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials.
    Anthony K; Cirak S; Torelli S; Tasca G; Feng L; Arechavala-Gomeza V; Armaroli A; Guglieri M; Straathof CS; Verschuuren JJ; Aartsma-Rus A; Helderman-van den Enden P; Bushby K; Straub V; Sewry C; Ferlini A; Ricci E; Morgan JE; Muntoni F
    Brain; 2011 Dec; 134(Pt 12):3547-59. PubMed ID: 22102647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Read-through approach for stop mutations in Duchenne muscular dystrophy. An update.
    Politano L
    Acta Myol; 2021 Mar; 40(1):43-50. PubMed ID: 33870095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Overview of Recent Therapeutics Advances for Duchenne Muscular Dystrophy.
    Mah JK
    Methods Mol Biol; 2018; 1687():3-17. PubMed ID: 29067652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When a mid-intronic variation of DMD gene creates an ESE site.
    Trabelsi M; Beugnet C; Deburgrave N; Commere V; Orhant L; Leturcq F; Chelly J
    Neuromuscul Disord; 2014 Dec; 24(12):1111-7. PubMed ID: 25193336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotype characterization and delayed loss of ambulation by glucocorticoids in a large cohort of patients with Duchenne muscular dystrophy.
    Zhang S; Qin D; Wu L; Li M; Song L; Wei C; Lu C; Zhang X; Hong S; Ma M; Wu S;
    Orphanet J Rare Dis; 2021 Apr; 16(1):188. PubMed ID: 33910603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and molecular characterization of a cohort of patients with novel nucleotide alterations of the Dystrophin gene detected by direct sequencing.
    Magri F; Del Bo R; D'Angelo MG; Govoni A; Ghezzi S; Gandossini S; Sciacco M; Ciscato P; Bordoni A; Tedeschi S; Fortunato F; Lucchini V; Cereda M; Corti S; Moggio M; Bresolin N; Comi GP
    BMC Med Genet; 2011 Mar; 12():37. PubMed ID: 21396098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic analysis of 62 Chinese families with Duchenne muscular dystrophy and strategies of prenatal diagnosis in a single center.
    Zhang J; Ma D; Liu G; Wang Y; Liu A; Li L; Luo C; Hu P; Xu Z
    BMC Med Genet; 2019 Nov; 20(1):180. PubMed ID: 31727011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newborn screening of duchenne muscular dystrophy specifically targeting deletions amenable to exon-skipping therapy.
    Beckers P; Caberg JH; Dideberg V; Dangouloff T; den Dunnen JT; Bours V; Servais L; Boemer F
    Sci Rep; 2021 Feb; 11(1):3011. PubMed ID: 33542429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular diagnosis of Duchenne muscular dystrophy.
    Nallamilli BR; Ankala A; Hegde M
    Curr Protoc Hum Genet; 2014 Oct; 83():9.25.1-29. PubMed ID: 25271841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation pattern in 606 Duchenne muscular dystrophy children with a comparison between familial and non-familial forms: a study in an Indian large single-center cohort.
    Polavarapu K; Preethish-Kumar V; Sekar D; Vengalil S; Nashi S; Mahajan NP; Thomas PT; Sadasivan A; Warrier M; Gupta A; Arunachal G; Debnath M; Keerthipriya MS; Pradeep-Chandra-Reddy C; Puttegowda A; John AP; Tavvala A; Gunasekaran S; Sathyaprabha TN; Chandra SR; Kramer B; Delhaas T; Nalini A
    J Neurol; 2019 Sep; 266(9):2177-2185. PubMed ID: 31139960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intron mutations and early transcription termination in Duchenne and Becker muscular dystrophy.
    Waldrop MA; Moore SA; Mathews KD; Darbro BW; Medne L; Finkel R; Connolly AM; Crawford TO; Drachman D; Wein N; Habib AA; Krzesniak-Swinarska MA; Zaidman CM; Collins JJ; Jokela M; Udd B; Day JW; Ortiz-Guerrero G; Statland J; Butterfield RJ; Dunn DM; Weiss RB; Flanigan KM
    Hum Mutat; 2022 Apr; 43(4):511-528. PubMed ID: 35165973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.
    Lee JJA; Saito T; Duddy W; Takeda S; Yokota T
    Methods Mol Biol; 2018; 1828():141-150. PubMed ID: 30171539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Point mutation and polymorphism in Duchenne/Becker muscular dystrophy (D/BMD) patients.
    Chaturvedi LS; Mukherjee M; Srivastava S; Mittal RD; Mittal B
    Exp Mol Med; 2001 Dec; 33(4):251-6. PubMed ID: 11795488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Genetic Diagnosis and Molecular Therapies for Duchenne Muscular Dystrophy].
    Takeshima Y
    Rinsho Byori; 2015 Oct; 63(10):1194-201. PubMed ID: 26897856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.